Research study · Cannabis Cannabinoid Res · 2025
Tetrahydrocannabivarin is Not Tetrahydrocannabinol
Verified on PubMed Oxford CEBM Level 5: Expert Clinical Review
A 2025 review in Cannabis Cannabinoid Res tested tetrahydrocannabinol in appetite. It helped clarify that tetrahydrocannabivarin is not intoxicating like tetrahydrocannabinol and has distinct effects at reported doses. This study confirms that tetrahydrocannabivarin and tetrahydrocannabinol are distinct compounds, a fact already well established in clinical practice.
In plain language
Study overview
Tetrahydrocannabivarin is Not Tetrahydrocannabinol
Findings
It helped clarify that tetrahydrocannabivarin is not intoxicating like tetrahydrocannabinol and has distinct effects at reported doses.
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
Tetrahydrocannabivarin (THCV) is a phytocannabinoid that is becoming popular across the North American cannabis market. THCV has been reported to reduce blood sugar and act as an appetite suppressant in several independent pre-clinical studies, which has earned it the popular nickname of "diet weed," despite few human studies of these effects. Additionally, THCV is usually and incorrectly categorized as an intoxicating analogue of tetrahydrocannabinol (THC), which causes confusion among both consumers and regulators.
In this article, we examine what is known pre-clinically and clinically about THCV, as well as highlight mechanisms of action, in order to clarify the scientific differences between THCV and THC. THCV, although structurally similar to THC, has distinct pharmacological activity and physiological effects at the doses currently reported in the literature. We highlight areas of opportunity for further THCV research in order to determine the full and appropriate potential for unique health, wellness, and therapeutic applications of this compound.
Source: the published abstract for PMID 38995871, shown in full while the plain-language summary above is reviewed.
The paper
Citation
Haghdoost M, Peters EN, Roberts M, Bonn-Miller MO Tetrahydrocannabivarin is Not Tetrahydrocannabinol. Cannabis Cannabinoid Res (2025). PubMed 38995871 · DOI
In practice
Why this matters
This study confirms that tetrahydrocannabivarin and tetrahydrocannabinol are distinct compounds, a fact already well established in clinical practice.
Frequently asked questions
Clinical Questions & Answers
What did this study show regarding Appetite depressants for Appetite?
It helped clarify that tetrahydrocannabivarin is not intoxicating like tetrahydrocannabinol and has distinct effects at reported doses.
How does Dr. Benjamin Caplan interpret these results for clinical practice?
This study confirms that tetrahydrocannabivarin and tetrahydrocannabinol are distinct compounds, a fact already well established in clinical practice.
Who participated in this trial and what methodology was used?
Tetrahydrocannabivarin is Not Tetrahydrocannabinol
Browse related research
Condition: Appetite Topic: Appetite depressants Topic: THC
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on September 20, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.